USFDA11 Sept 2026, 09:50 pm
Strides Pharma Alathur Facility Completes USFDA Inspection
AI Summary
Strides Pharma Science Ltd announced the completion of a routine USFDA inspection at its formulation facility in Alathur, Chennai. The inspection took place from September 2 to September 11, 2026. The USFDA issued a Form 483 with three observations. The company stated it will respond to these observations within the stipulated time and will inform the stock exchanges of any further updates.
Key Highlights
- USFDA inspection concluded at Alathur formulation facility.
- Three observations were noted in the Form 483 issued.
- Company to respond to observations within the stipulated timeframe.
- Further updates will be provided to stock exchanges as necessary.
Price Impact
More from STAR